Commerce.com CMRC
Commerce.com names interim CFO
Item 2.02 Reports results, Item 5.02 Executive or director change, Item 7.01 Investor disclosure
- Form
- 8-K
- Filed
- Importance
- Major
- Accession
- 0001193125-26-448533
- Daniel Lentz steps down as CFO and COO on Nov 13, 2026
- Tyler Duncan appointed as interim CFO with $350,000 annual salary
- Duncan to receive $300,000 retention bonus over 2027
- Chuck Cassidy to get $150,000 retention bonus and 25,000 RSUs (shares paid out over time)
Written from the 8-K on EDGAR. AI can make mistakes. Check the filing.
The reading, claim by claim
- The filing includes a press release with forward-looking statements and cautionary language.
- The information in Item 2.02 is furnished and not filed, and not incorporated by reference in other filings.
- On November 3, 2026, Daniel Lentz, the Chief Financial Officer, announced his departure effective November 13, 2026.
- Tyler Duncan was appointed as Interim Chief Financial Officer.
- Mr. Duncan will receive a base salary of $350,000 and a retention bonus of $300,000, payable in installments.
- The Company also approved a retention letter for Chuck Cassidy, the General Counsel, providing a $150,000 retention bonus and 25,000 RSUs.
6 of 7 claims matched the filing text.
Not found in the filing text
- The RSUs will vest over four years.
For perspective, checked against its own source
From the 10-Q for the quarter ended September 30, 2026
- In its 10-Q for the quarter ended September 30, 2026, Commerce.com, Inc. reported revenue of $84.2 million and a net loss of $3.2 million.
From the filing
Item 2.02 Results of Operations and Financial Condition.
Item 2.02 Results of Operations and Financial Condition.
On November 5, 2026, Commerce.com, Inc. (the "Company") issued a press release announcing financial results as of and for the three and nine months ended September 30, 2026. The press release contains forward-looking statements regarding the Company, and includes cautionary statements identifying important factors that could cause actual results to differ materially from those anticipated.1 A copy of the press release issued November 5, 2026 is furnished herewith as Exhibit 99.1.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; App
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Chief Financial Officer
On November 3, 2026 Daniel Lentz, the Chief Financial Officer and Chief Operating Officer of the Company, informed the Company that he will be stepping down from his positions as Chief Financial Officer (the Company's principal financial officer) and Chief Operating Officer effective as of November 13, 2026.3 Mr. Lentz's decision was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
On November, 3, 2026 the board of directors of the Company appointed Tyler Duncan, age 36, to serve as the Company's Interim Chief Financial Officer, effective as of Mr. Lentz's departure, until a permanent successor is named.4 In this role, Mr. Duncan will serve as the Company's principal financial officer. The Company has commenced a search for a permanent Chief Financial Officer.
Mr. Duncan has served as Senior Vice President, Finance and Investor Relations of the Company since November 2025. He was previously Vice President, Finance and Investor Relations from September 2024 to November 2025. Before that, Mr. Duncan held several finance roles at the Company: Senior Director, Finance and Investor Relations (2023–2024); and Director of Financial Planning and Analysis (2021–2023). He holds a Bachelor's degree from Baylor University.
In connection with Mr. Duncan's appointment as Interim Chief Financial Officer, the Company entered into an offer letter with Mr. Duncan (the "Duncan Offer Letter"), pursuant to which Mr. Duncan: will be eligible to (i) receive an annual base salary of $350,000 and (ii) participate in the Company's annual incentive award program, with a target bonus of $122,500.5 5Pursuant to the Duncan Offer Letter, Mr. Duncan will also be eligible to receive a one-time cash award in the aggregate amount of $300,000 (the "Duncan Retention Bonus").5 The Duncan Retention Bonus is payable as to $200,000 on the first available payroll date following May 31, 2027 (the "First Duncan Retention Date"), and as to the remaining $100,000 on the first available payroll date following August 31, 2027 (the "Second Duncan Retention Date" and together with the First Duncan Retention Date, the "Duncan Retention Dates"), subject to Mr. Duncan's continued employment through the applicable Duncan Retention Date. If Mr. Duncan gives notice of resignation prior to the applicable Duncan Retention Date, he will forfeit the corresponding Duncan Retention Bonus installment. In addition, Mr. Duncan will be granted an award of 125,000, restricted stock units ("RSUs") covering shares of the Company's common stock which will vest ratably over a four-year period subject to Mr. Duncan's continued service with the Company through the applicable vesting date (subject to accelerated vesting as described below).
Under the Duncan Offer Letter, if Mr. Duncan's employment is terminated by the Company without Cause or he resigns for Good Reason (each as defined in the Duncan Offer Letter) (each, a "Qualifying Termination"), in either case more than three months before or more than 18 months after the consummation of a Change in Control (as defined in the Duncan Offer Letter), subject to his timely execution and non-revocation of a general release of claims, he will be entitled to (i) an amount equal to six months of his annual base salary and (ii) an amount equal to six months of the Company's share of healthcare premiums for Mr. Duncan and his eligible dependents. If such Qualifying Termination occurs within three months prior to or 18 months following a Change in Control, subject to his timely execution and non-revocation of a general release of claims, Mr. Duncan will instead be entitled to (i) an amount equal to 12 months of his annual base salary, (ii) an amount equal to 12 months of the Company's share of healthcare premiums for Mr. Duncan and his eligible dependents and (iii) if such Qualifying Termination occurs within three months prior to or 12 months following the Change in Control, full vesting of all of his then-outstanding and unvested equity awards.
The foregoing description of the Duncan Offer Letter does not purport to be complete and is qualified in its entirety by reference to the full text of the Duncan Offer Letter, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference.
There are no arrangements or understandings between Mr. Duncan and any other persons pursuant to which he was appointed as Interim Chief Financial Officer, no family relationships among any of the Company's directors or executive officers and Mr. Duncan, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Executive Officer Compensation - Retention Award
The Retention Bonus is payable as to $100,000 on the first available payroll date following May 31, 2027 (the "First Cassidy Retention Date"), and as to the remaining $50,000 on the first available payroll date following August 31, 2027 (the "Second Cassidy Retention Date" and, together with the First Cassidy Retention Date, the "Cassidy Retention Dates"), subject to Mr
Item 7.01 Regulation FD Disclosure.
Item 7.01 Regulation FD Disclosure.
On November 5, 2026, the Company issued a press release announcing the departure of Mr. Lentz and the appointment of Mr. Duncan as Interim Chief Financial Officer, in each case effective November 13, 2026. A copy of the press release is attached hereto as Exhibit 99.1.
The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Similar companies
Companies of similar size in SIC 7372 and related industry codes: the same peer list as the financial tables.
- Veradigm MDRX public float $408M, Jun 30, 2025
- GoodRx Holdings GDRX public float $423M, Jun 30, 2025
- Playtika Holding PLTK public float $363M, Jun 28, 2025
- Bandwidth BAND public float $431M, Jun 30, 2025
- IBEX IBEX public float $431M, Dec 31, 2025
